2 stories in the last 7 days
The latest houdini bio news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks houdini bio across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Houdini Bio exited stealth with €1.7 million in pre-Seed funding led by SCVC. The British biotech startup's platform designs DNA sequences to overcome biological barriers in genetic medicines. The funding allowed the company to validate its technology and hit technical milestones in a third of the predicted time.

Houdini Bio raised £1.5 million in grants and pre-seed funding led by SCVC. The startup's software redesigns therapeutic DNA to evade the HUSH protein complex, which causes gene therapies to lose effectiveness. The discovery came from CEO Jonathan Cohen-Gold's Cambridge PhD research.
Summaries by ByteBrief